Brought to you by Helsinn Therapeutics (U.S.), Inc.
Helsinn is proud to offer a live, virtual symposium for attendees of 2021 Oncology Nursing Society (ONS) Annual Congress.
Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV): A Case-Based Presentation will provide attendees with a better understanding of:
- A patient’s risk for CINV during highly and moderately emetic chemotherapy regimens
- Current guideline recommendations for prevention of CINV
- The role that a 5-HT3 + NK-1 receptor antagonist plays in prevention of CINV
Click here for more information about a treatment option for CINV.
Be sure to register for this year’s ONS Congress and attend this live, virtual presentation on April 20, 2021 at 3:00 PM ET, delivered by Faith Mutale, CRNP,of the Abramson Cancer Center of the University of Pennsylvania (Philadelphia, PA). Learn more about the session here.